Prescribing Responsibility and Shared Care in NHS Community Services

Prescribing in NHS community services rarely sits neatly with a single professional or organisation. Responsibility often spans hospital specialists, GPs, community clinicians and, indirectly, social care staff supporting administration or monitoring. Where shared care arrangements are poorly defined, risk increases quickly—missed reviews, delayed monitoring, inappropriate continuation of medicines, or unsafe delegation. This article supports Medicines Management, Prescribing & Delegated Healthcare and aligns with Service Models & Care Pathways, because prescribing safety depends on clear pathway ownership and auditable accountability.

Why prescribing responsibility becomes blurred

Shared care is now routine across community pathways: specialist initiation with GP continuation, community nurse monitoring, and social care support with prompts or administration. Problems arise when services assume responsibility has transferred without explicit confirmation, or when changes made in one setting are not reconciled in another. For people with complex needs, cognitive impairment or chaotic engagement, the consequences can be serious and prolonged.

Safe prescribing in the community is not just about who signs the prescription. It is about who monitors, who reviews, who responds to deterioration, and who escalates when reviews are missed. Commissioners and inspectors increasingly expect these responsibilities to be explicit and evidenced.

Operational example 1: Shared care for high-risk medicines

Context: A community mental health interface pathway supports people prescribed lithium and antipsychotics initiated by secondary care. Monitoring responsibilities are split between GP and community teams, but blood tests are frequently missed.

Support approach: The pathway formalised shared care responsibility with explicit monitoring ownership and escalation routes.

Day-to-day delivery detail: At entry, staff record the named prescriber, monitoring schedule, and responsible clinician for follow-up. A monitoring tracker flags upcoming and missed tests. If a test is missed, staff contact the person to offer practical support and notify the GP practice the same day. Repeated missed monitoring triggers senior clinical review and, where appropriate, a shared decision about pausing or adjusting treatment, documented with capacity considerations.

How effectiveness or change is evidenced: The service audits monitoring compliance, time-to-escalation, and medicine-related incidents. Evidence shows reduced prolonged lapses in monitoring and clearer documentation of shared decision-making.

Operational example 2: Prescribing changes during crisis escalation

Context: A rapid response community pathway frequently encounters prescribing changes made during urgent GP or out-of-hours reviews, which are not communicated back to the core team.

Support approach: The service embedded a prescribing change verification step following any crisis contact.

Day-to-day delivery detail: After urgent reviews, staff confirm current medicines with the prescriber and update the shared record. Any temporary changes are flagged with review dates. Social care staff supporting administration receive updated instructions the same day, and old MARs are withdrawn. Supervisors check that verification has occurred during daily huddles.

How effectiveness or change is evidenced: Incident reviews show fewer errors linked to outdated MARs and reduced duplication of medicines following crisis episodes.

Operational example 3: Prescribing responsibility where capacity fluctuates

Context: A community frailty pathway supports people with fluctuating capacity who intermittently refuse medicines or question their purpose.

Support approach: The pathway strengthened links between prescribing review, capacity assessment and best-interest decision-making.

Day-to-day delivery detail: When refusal persists, staff request a timely prescribing review rather than defaulting to repeated prompts. Capacity assessments are documented, and best-interest decisions are made with multidisciplinary input. Any changes to medicines are communicated clearly to all supporting staff, with review dates recorded.

How effectiveness or change is evidenced: Records show clearer rationale for continuation or change, reduced conflict with families, and fewer safeguarding concerns related to covert or inappropriate administration.

Commissioner expectation: Clear shared care governance

Commissioner expectation: Commissioners expect shared care arrangements to be explicit, consistent and auditable. This includes clarity on prescribing responsibility, monitoring ownership, escalation routes and review intervals. Commissioners will test whether pathways can demonstrate how prescribing risk is managed for people who miss reviews or struggle to engage.

Regulator / Inspector expectation: Safe prescribing systems and learning

Regulator / Inspector expectation (CQC): CQC expects providers to have safe prescribing systems, accurate records and evidence of learning from incidents. Inspectors will look for clarity on shared care, appropriate monitoring, and how services respond when prescribing arrangements break down.

Governance and assurance: making prescribing accountability visible

Effective governance includes shared care registers, monitoring audits, incident trend review and routine assurance that prescribing changes are communicated and acted upon. When services can evidence these controls, prescribing risk becomes manageable rather than hidden.

---